Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, it is possible to inject semaglutide incorrectly, and some mistakes matter more than others. The good news is that most common errors (wrong site, missed rotation, slightly off angle) do not make the medicine dangerous, but they can affect how well it absorbs and how comfortable the injection is. Semaglutide (Wegovy) is a prescription-only medicine; a prescriber reviews your suitability before you receive it, and the Patient Information Leaflet that arrives with your pen covers technique in detail. This page works through the mistakes that actually come up, what they mean, and when to seek advice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is some version of: "I think I did it wrong, did I just waste a dose?" The honest answer is that semaglutide is a forgiving medicine when it comes to minor technique variations. A small deviation in needle angle, injecting fractionally too close to the navel, or pinching the skin more firmly than instructed rarely means the medicine failed to absorb. The subcutaneous fat layer across the abdomen, outer thigh, and upper arm is large enough that small positional differences make little practical difference in most people.
What does matter is injecting into that fatty layer rather than into muscle. Semaglutide's pharmacokinetics assume a subcutaneous depot; intramuscular injection can speed absorption unpredictably and increase the likelihood of nausea. If you are very lean or injecting into the arm, using the suggested needle length and pinching a fold of skin reduces the risk of going too deep. The full injection technique guide on this site walks through that step by step.
The myth to correct, then, is that any imperfection ruins the dose. Most do not. The errors worth taking seriously are the ones covered in the sections below.
The pen itself is robust. The needle is not. Using a bent needle, one that has been left on the pen between injections, or a needle you have used before are the most consistent sources of genuine problems: blocked flow, incomplete dose delivery, and increased injection-site pain or bruising.
Novo Nordisk's instructions specify attaching a new needle immediately before each injection and removing it straight after. Leaving a needle in place between doses allows air to enter the pen and medication to leak or crystallise at the tip, either of which can mean the next dose does not dispense fully. You will not always be able to tell from the dose counter whether this has happened.
Checking that the flow check (the small test before the first injection from a new pen) produces a stream and not just a droplet is a useful early warning sign. If the pen clicks through the full dose but you saw no or very little liquid at the skin surface, that is worth reporting to your prescribing team rather than injecting again. The guide to self-injection technique has a section specifically on troubleshooting the dose counter.
Disposing of used needles safely matters too. A proper sharps container keeps them secure until collection, household bins are not appropriate.
Injecting repeatedly into exactly the same small patch of skin causes lipohypertrophy, a thickening of the tissue that reduces absorption and leaves a lumpy area that can be uncomfortable. The three approved sites (abdomen, thigh, upper arm) exist partly so that rotation is practical without running out of usable skin.
Within each site, move the injection point by at least a couple of centimetres each week. A simple system (working around the clock face of your abdomen, for example) is easier to remember than trying to recall last week's exact spot. Redness, mild bruising, or a small bump at the site are common and usually settle within a day or two. Persistent swelling, hard nodules, or skin that looks infected need clinical attention rather than watchful waiting.
The licensed sites do not include the inner arm, the inner thigh, or areas near joints, scars, or bruised skin. Injecting close to the navel (within about 5 cm) is also advised against in the product instructions. For a closer look at what the research and guidance say about site selection, the dedicated page on wrong injection spots covers the evidence in more detail.
The NHS semaglutide medicines page lists the common side effects associated with injections, most are mild and linked to technique or early tolerance rather than an error that requires medical review.
Most injection errors are recoverable without any intervention. A few are not. Seek prompt medical advice if you experience: signs of a serious allergic reaction (swelling of the face, lips, or throat, difficulty breathing, rash spreading from the injection site); severe pain or hardness at the site that gets worse rather than better over 48 hours; or any concern that you have accidentally injected into a vein rather than subcutaneous tissue (unusual immediate burning or stinging along a vein line).
If you are genuinely uncertain whether a full dose was delivered, the standard guidance from the Patient Information Leaflet applies: do not administer an additional dose. Skip to your next scheduled weekly injection. Doubling up to compensate risks the concentrated GI side effects that the slow titration schedule is specifically designed to avoid.
The "I injected Wegovy wrong" page addresses specific scenarios (pen held at the wrong angle, dose counter confusion, accidental early re-injection) with direct answers to each. For questions about the weekly schedule and what to do after a missed dose, the frequency and timing guide is the right starting point.
Wegovy is a prescription medicine reviewed clinically before and during treatment. If technique questions come up after you start (they often do) your prescribing team is the fastest route to a clear answer. You can read more about what Wegovy treatment involves or, if you are still deciding whether it is the right route, start a free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.